Amgen (AMGN) Tops Q3 EPS by 60c, Offers Guidance
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $347.01 +0.66%
Revenue Growth %: +2.7%
Financial Fact:
Interest expense, net: 325M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +2.7%
Financial Fact:
Interest expense, net: 325M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q3 EPS of $5.64, $0.60 better than the analyst estimate of $5.04. Revenue for the quarter came in at $9.56 billion versus the consensus estimate of $8.98 billion.
GUIDANCE:
Amgen sees FY2025 EPS of $20.60-$21.40, versus the consensus of $21.04. Amgen sees FY2025 revenue of $35.8-36.6 billion, versus the consensus of $35.64 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook
- Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
- Wealthfront launches custodial account with tax-gain harvesting
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
